Special Clinical Trainings

• Cancer Genomics and Precision Oncology
• Immuno Oncology / Immune Cell therapy / Cancer vaccine

Special Clinical Interests

• Advanced Technology in Cancer Omics (Multi omics approach)
• Personalized cancer treatment /  Precision cancer medicine

Conditions Treated (Disease)

• All Solid malignancies : Breast cancer, Lung cancer, Colon cancer, Hepatobiliary cancer etc.

Publications

1. A phase II single-center study of the tolerability and efficacy of TBX-3400 in subjects with chronic HBV or hepatitis virus associated liver tumors resistant or refractory to standard therapies. (Principle Investigator)
2. Development of patient – derived organoids with accompanying molecular and anti- cancer drug response data for precision oncology. (Co-Investigator)
3. Development of AI-assisted software for holistic need assessment in cancer patients to promote individualized cancer care. (Principle Investigator)
4. Identification of Immunogenic Personal Tumor-Specific Mutations and Neoantigens from Solid tumor or Liquid biopsy (Principle investigator)
5. Personalized neoantigen peptide vaccine for cancer treatment (Principle investigator)

Journal Affiliations
2016

• Correlation of Mitotic Index and Ki-67 and Their Impacts on Survival of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at Ramathibodi Hospital. Annals of Oncology, Volume 27, Supplement 2, June 01, 2016.  Poster Presentation at ESMO World GI Congress, Barcelona, Spain.

2014

• Prevalence and risk factors for deep vein thrombosis in hospitalized high-risk patients at a tertiary care hospital in Thailand.  Asian Biomedicine Vol.8 No.6, December ; 759 – 762